News
In a paper published in Science Bulletin, a Chinese team of scientists led by Professor Bao revealed that the ...
Primary neuroendocrine carcinoma of the male breast is an exceptionally rare entity, with fewer than 50 cases documented in ...
Wrestler Dmitriy Baboryko of Russia has accepted a two-year period of ineligibility after testing positive for the ...
Russia's Dmitry Baboryko has been suspended until December 2026 after testing positive for tamoxifen at the U-23 World ...
Russian wrestler Dmitry Baboryko was banned for two years after testing positive for the drug Tamoxifen, which is used by breast cancer patients and is a banned substance in compet ...
Dmitry Baboryko, a Russian wrestler, receives a two-year ban for testing positive for tamoxifen, a breast cancer drug masking steroid use. The ban follows his performance at an international ...
Baboryko tested positive for tamoxifen at the under-23 world championships last October in Albania, the International Testing Agency said on announcing the ban on behalf of the United World Wrestling ...
Loss function of tumor suppressor FRMD8 confers resistance to tamoxifen therapy via a dual mechanism
Program for Cancer and Cell Biology, Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences; Peking University International Cancer Institute; and State Key Laboratory ...
Loss function of tumor suppressor FRMD8 confers resistance to tamoxifen therapy via a dual mechanism
Tamoxifen resistance is a common problem in partially ER-positive patients undergoing endocrine therapy, and this manuscript has important research significance as it is based on clinical practical ...
What Is Invasive Lobular Carcinoma? Invasive lobular carcinoma (ILC) is a type of breast cancer. It begins in lobules — the cells of the mammary glands that make milk — and spreads to other ...
Tamoxifen, which is prescribed for the treatment of breast cancer, can interact with some commonly used drugs and over-the-counter nutritional supplements. You may be taking tamoxifen for at least ...
Defensive lineman Michael Hoecht and defensive tackle Larry Ogunjobi were each banned six games for violating the NFL Performance Enhancing Drug policy, Bills general manager Brandon Beane said at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results